Meningitis is a substantial contributor to mortality in children younger than 5 years of age in low- and middle-income countries.

Results of a small study suggest similar pathophysiology of cognitive dysfunction and neuropathic pain in patients with long COVID.

Timely remdesivir treatment in immunocompromised patients infected with COVID-19 is associated with improved survival outcomes.

Children with health care-associated vs nonhealth care-associated RSV were more likely to require escalation of respiratory support.

Adhering to a healthy prenatal diet may reduce patterns of infant growth outside reference ranges, according to study findings.

Work-time, rather than leisure-time or nonworkday, activity behavior seems to be associated with 24-hour ambulatory blood pressure.

Among health care personnel, influenza vaccination has not returned to 2019 levels, and COVID-19 vaccinations have been decreasing.

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among nursing home residents early in the 2024 to 2025 season.

Lithium aspartate does not provide significant relief for post-COVID-19 symptoms of fatigue or cognitive dysfunction.

Mpox risk factors among MSM and transgender adults include intimate close contact, especially condomless receptive anal sex.

In utero exposure to COVID-19 infection during pregnancy is not associated with impaired neurodevelopmental outcomes in children through age 24 months.

Remdesivir treatment reduces the risk for 30-day COVID-19-related hospital readmission among all patients discharged alive from initial hospitalization.